Artios Pharma

Artios Pharma

Latest funding
£65,000,000
Venture capital (Series B) - 2018
Novartis Venture Fund IP Group Plc Arix Bioscience +6
$33,200,000
Venture capital (Series A) - 2016
Imperial Innovations SV Life Sciences Arix Bioscience +3
Team Size
1–10
Employees
£65,000,000 Venture capital (Series B)
FinSMEs

DNA Damage Response Company Artios Pharma Raises £65M in Series B

Funding Science
$33,200,000 Venture capital (Series A)
FinSMEs

Artios Pharma Raises $33.2M in Series A Funding

Funding Health